UPDATE: Morgan Stanley Reiterates Overweight Rating, Removes PT on athenahealth on News of New CFO Hiring

In a report published Wednesday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Overweight rating on

, but removed the $192.00 price target. In the report, Morgan Stanley noted, “Next catalyst is 2Q14 earnings in mid-July. Given that Kristi Matus' start date is July 21st, we do not expect a significant presence on the earnings CC by the new CFO. During the call we will focus on gross margin trends, the rollout of Coordinator Enterprise at Steward Healthcare and Griffin Hospital, and for the core ambulatory market, Collector physician addition metrics as well as color on the rollout of key Enteprise deals, particularly Ascension Health and HPP.” athenahealth closed on Tuesday at $122.97.